Staff Contact: Keri Barclay
The FDA and CDC recently approved and authorized the updated COVID-19 monovalent vaccines for 2024-2025. The recommendations are for the Moderna and Pfizer-BioNTech vaccines for use in individuals 6 months of age and older. These updated vaccines are more closely paired with the currently circulating variants, and all eligible individuals are encouraged to seek vaccination even if they have been previously vaccinated for COVID-19.
The 2023-2024 Novavax COVID-19 vaccine remains authorized but is no longer available in the United States as all doses have expired. The CDC recommendations for use of the Novavax COVID-19 vaccine have been removed from the interim clinical considerations.